ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201. A total of 126 filers reported holding ACHILLION PHARMACEUTICALS IN in Q1 2018. The put-call ratio across all filers is 0.11 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $163,000 | +85.2% | 26,948 | +8.5% | 0.00% | – |
Q3 2019 | $88,000 | +166.7% | 24,848 | +102.0% | 0.00% | – |
Q2 2019 | $33,000 | -10.8% | 12,298 | 0.0% | 0.00% | – |
Q1 2019 | $37,000 | +76.2% | 12,298 | -10.9% | 0.00% | – |
Q4 2018 | $21,000 | -60.4% | 13,798 | -4.8% | 0.00% | – |
Q3 2018 | $53,000 | +29.3% | 14,498 | +0.7% | 0.00% | – |
Q2 2018 | $41,000 | -22.6% | 14,398 | 0.0% | 0.00% | – |
Q1 2018 | $53,000 | +39.5% | 14,398 | +8.3% | 0.00% | – |
Q4 2017 | $38,000 | – | 13,300 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RA Capital Management | 13,633,220 | $57,396,000 | 7.04% |
HealthInvest Partners AB | 497,807 | $2,096,000 | 3.21% |
BVF INC/IL | 3,285,400 | $13,832,000 | 2.35% |
EMORY UNIVERSITY | 486,438 | $2,048,000 | 1.93% |
Marcus Capital, LLC | 69,400 | $1,751,000 | 1.63% |
DAFNA Capital Management LLC | 196,500 | $827,000 | 0.70% |
Orbimed Advisors | 13,107,200 | $55,181,000 | 0.62% |
Rock Springs Capital Management LP | 1,500,000 | $6,315,000 | 0.36% |
Spark Investment Management LLC | 710,100 | $2,989,000 | 0.19% |
TURNER INVESTMENTS LLC | 65,420 | $275,000 | 0.18% |